Alvopem® (pemetrexed) safety assessment in patients with non-small cell lung cancer or malignant pleural mesothelioma: a post-marketing surveillance

被引：0
作者：
Sharareh Seifi
Babak Salimi
Zahra Esfahani Monfared
Cyrus Sabahi
Hamidreza Kafi
Adnan Khosravi
机构：
[1] National Research Institute of Tuberculosis and Lung Diseases (NRITLD),Chronic Respiratory Disease Research Center
[2] Shahid Beheshti University of Medical Sciences,Faculty of Pharmacy
[3] Tehran University of Medical Sciences,Medical Department
[4] Orchid Pharmed Company,undefined
[5] Masih Daneshvari Hospital,undefined
来源：
Journal of Pharmaceutical Policy and Practice | / 16卷
关键词：
Non-small cell lung cancer; Observational study; Pemetrexed; Post-marketing surveillance; Safety;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
[21]   Safety profiles of non-small cell lung cancer patients treated with pemetrexed plus carboplatin: a real-world retrospective, observational, cohort study [J].
Chen, Lei ;
San Antonio, Belen ;
Yan, Yu ;
Chen, Jian ;
Goodloe, Robert J. ;
John, William J. .
CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 (05) :931-936
[22]   Efficacy of bevacizumab through an indwelling pleural catheter in non-small cell lung cancer patients with symptomatic malignant pleural effusion [J].
Zeng, Hao ;
Zhang, Yuanyuan ;
Tan, Sihan ;
Huang, Qin ;
Pu, Xin ;
Tian, Panwen ;
Li, Yalun .
BMC PULMONARY MEDICINE, 2024, 24 (01)
[23]   Efficacy and safety of immunotherapy in elderly patients with non-small cell lung cancer [J].
Galli, Giulia ;
De Toma, Alessandro ;
Pagani, Filippo ;
Randon, Giovanni ;
Trevisan, Benedetta ;
Prelaj, Arsela ;
Ferrara, Roberto ;
Proto, Claudia ;
Signorelli, Diego ;
Ganzinelli, Monica ;
Zilembo, Nicoletta ;
de Braud, Filippo ;
Garassino, Marina Chiara ;
Lo Russo, Giuseppe .
LUNG CANCER, 2019, 137 :38-42
[24]   Intrapleural administration of cisplatin and etoposide to treat malignant pleural effusions in patients with non-small cell lung cancer [J].
Tohda, Y ;
Iwanaga, T ;
Takada, M ;
Yana, T ;
Kawahara, M ;
Negoro, S ;
Okishio, K ;
Kudoh, S ;
Fukuoka, M ;
Furuse, K .
CHEMOTHERAPY, 1999, 45 (03) :197-204
[25]   Development and validation of the CAIL prognostic score in non-small cell lung cancer patients with malignant pleural effusion [J].
Li, Tianyuan ;
Tian, Panwen ;
Huang, Qin ;
Zeng, Hao ;
Wei, Qi ;
Li, Yalun .
CLINICAL RESPIRATORY JOURNAL, 2023, 17 (11) :1158-1168
[26]   Surveillance of resected non-small cell lung cancer [J].
A. López-González ;
P. Ibeas Millán ;
B. Cantos ;
M. Provencio .
Clinical and Translational Oncology, 2012, 14 :721-725
[27]   Surveillance of resected non-small cell lung cancer [J].
Lopez-Gonzalez, A. ;
Ibeas Millan, P. ;
Cantos, B. ;
Provencio, M. .
CLINICAL & TRANSLATIONAL ONCOLOGY, 2012, 14 (10) :721-725
[28]   Safety Profile of Oxaliplatin in 3,687 Patients With Cancer in China: A Post-Marketing Surveillance Study [J].
Yu, Zaoqin ;
Huang, Rui ;
Zhao, Li ;
Wang, Ximin ;
Shangguan, Xiaofang ;
Li, Wei ;
Li, Min ;
Yin, Xianguo ;
Zhang, Chengliang ;
Liu, Dong .
FRONTIERS IN ONCOLOGY, 2021, 11
[29]   Pseudocellulitis in the Setting of Pemetrexed Treatment for Non-Small Cell Lung Cancer [J].
Nguyen, Cassidy M. ;
Robertson, Jake C. ;
Cardenas, Adam ;
Martinez, Edgar ;
Keeling, Brett H. ;
Nguyen, Khang D. .
JOURNAL OF CUTANEOUS PATHOLOGY, 2025, 52 (04) :284-286
[30]   Pemetrexed-induced Typhlitis in Non-small Cell Lung Cancer [J].
Shvartsbeyn, Marianna ;
Edelman, Martin J. .
JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (10) :1188-1190
12345